Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links 
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge 
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks 
Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape 
Washington Post Publisher Will Lewis Steps Down After Layoffs 
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch 
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing 
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine 
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate 
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates 
Hims & Hers Halts Compounded Semaglutide Pill After FDA Warning 
Ford and Geely Explore Strategic Manufacturing Partnership in Europe 
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports 
Nasdaq Proposes Fast-Track Rule to Accelerate Index Inclusion for Major New Listings 
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026 
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains 
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences 
SAN JOSE, Calif., Jan. 03, 2017 -- Satellite Healthcare, a leading not-for-profit dialysis care provider, is pleased to announce that the Norman S. Coplon Extramural Grant Program is now accepting applications for 2017.
Named after the Stanford University nephrologist who founded Satellite Healthcare, the Norman S. Coplon Extramural Grant Program has become one of the nation's largest private research endowments for kidney disease treatment. Since 2000, the program has funded over $15 million in research to improve the lives of patients. Each 2017 grant recipient will be awarded $200,000 over two years.
The Satellite Healthcare Norman S. Coplon Extramural Grant Program is no longer limited to young researchers, and calls for applications by clinicians and scientists with a passion and expertise in the applied pragmatic clinical research arena focused in two areas:
- Home Dialysis Dropout Reduction: Opportunities for improving care to reduce dropout rates in home dialysis
- Dialysis Delivery Process Improvement: Procedural improvements aimed at optimization of dialysis delivery to enhance patient capabilities, patient experience and reduce hospitalizations/re-hospitalizations
Satellite Healthcare invites qualified United States researchers to apply for the 2017 Norman S. Coplon Extramural Grant Program. The application period is open until 5:00PM PST on February 10th, 2017. Applications and further details on the application process, criteria and qualifications are available online at: www.satellitehealth.com/research. Grant winners will be announced in August, 2017.
About Satellite Healthcare:
Satellite Healthcare, Inc. has been among the nation's leading not-for-profit providers of kidney dialysis and related services since 1974. Through its affiliated services, Satellite WellBound, Satellite Dialysis, and Satellite Research, Satellite Healthcare provides unparalleled early patient wellness education, personalized clinical services and a complete range of dialysis therapy choices. According to the Centers for Medicare & Medicaid Services (CMS) Five-Star Quality Rating System, Satellite leads the industry in four to five stars rating among the 10 largest national dialysis providers. In addition, Satellite Healthcare has a well-recognized, enduring commitment to philanthropy and community service, from funding millions of dollars in research grants to sponsoring kidney programs nationwide. Satellite is committed to advancing the standard of chronic kidney disease care so patients can enjoy a better life.
Media Contact: Kyle McGuire, (925) 790-2788, [email protected]
